We are live on ! Find out more
Nisa Investment Advisors

Nisa Investment Advisors Portfolio holdings

AUM $32B
1-Year Est. Return 32.86%
This Fund
S&P 500
This Quarter Est. Return
-3.41%
1 Year Est. Return
+32.86%
3 Year Est. Return
+108.44%
5 Year Est. Return
+138.89%
10 Year Est. Return
+505.54%
AUM
$14.2B
AUM Growth
+$857M
Cap. Flow
+$862M
Cap. Flow %
6.07%
Top 10 Hldgs %
24.93%
Holding
2,444
New
306
Increased
502
Reduced
1,082
Closed
89

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$772M
2
AMZN icon
Amazon
AMZN
+$312M
3
BAC icon
Bank of America
BAC
+$116M
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$81.2M
5
ABT icon
Abbott
ABT
+$70.7M

Sector Composition

Rank Sector Weight
1 Technology 22.73%
2 Healthcare 12.42%
3 Financials 12.14%
4 Consumer Discretionary 9.24%
5 Industrials 8.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTRN icon
2226
Citi Trends
CTRN
$618M
$9K ﹤0.01%
+300
New +$14K
CXW icon
2227
CoreCivic
CXW
$3.26B
$9K ﹤0.01%
780
-320
-29% -$3.13K
DTIL icon
2228
Precision BioSciences
DTIL
$206M
$9K ﹤0.01%
+93
New +$12.6K
GEF.B icon
2229
Greif Class B
GEF.B
$4.15B
$9K ﹤0.01%
140
-60
-30% -$3.54K
GH icon
2230
Guardant Health
GH
$22.4B
$9K ﹤0.01%
134
-781
-85% -$53.4K
HRMY icon
2231
Harmony Biosciences
HRMY
$2.27B
$9K ﹤0.01%
177
IBRX icon
2232
ImmunityBio
IBRX
$7.94B
$9K ﹤0.01%
+1,600
New +$9.82K
CHUY
2233
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
$9K ﹤0.01%
320
-130
-29% -$3.61K
GOEV
2234
DELISTED
Canoo Inc. Class A Common Stock
GOEV
$9K ﹤0.01%
+4
New +$11K
EVLO
2235
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$9K ﹤0.01%
+130
New +$10.8K
ABUS icon
2236
Arbutus Biopharma
ABUS
$907M
$8K ﹤0.01%
+2,700
New +$8.27K
ACLS icon
2237
Axcelis
ACLS
$4.1B
$8K ﹤0.01%
+100
New +$6.83K
ANIP icon
2238
ANI Pharmaceuticals
ANIP
$1.72B
$8K ﹤0.01%
290
-1,220
-81% -$45.5K
AVTR icon
2239
Avantor
AVTR
$9.29B
$8K ﹤0.01%
237
-8,625
-97% -$308K
BOLT icon
2240
Bolt Biotherapeutics
BOLT
$7.67M
$8K ﹤0.01%
+155
New +$10.4K
CZNC icon
2241
Citizens & Northern Corp
CZNC
$454M
$8K ﹤0.01%
320
-140
-30% -$3.55K
EIG icon
2242
Employers Holdings
EIG
$881M
$8K ﹤0.01%
200
ENOV icon
2243
Enovis
ENOV
$1.4B
$8K ﹤0.01%
116
FF icon
2244
Future Fuel
FF
$226M
$8K ﹤0.01%
850
-350
-29% -$2.84K
MAXN
2245
DELISTED
Maxeon Solar Technologies
MAXN
$8K ﹤0.01%
6
RXRX icon
2246
Recursion Pharmaceuticals
RXRX
$1.76B
$8K ﹤0.01%
+1,080
New +$11.5K
SANA icon
2247
Sana Biotechnology
SANA
$1B
$8K ﹤0.01%
980
-830
-46% -$6.71K
WW
2248
DELISTED
WW International
WW
$8K ﹤0.01%
+820
New +$9.62K
LGTY
2249
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$8K ﹤0.01%
+370
New +$8.18K
ORAN
2250
DELISTED
Orange
ORAN
$8K ﹤0.01%
708

Similar funds

Nisa Investment Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Nisa Investment Advisors held 2,444 positions worth $14.2B, up 6.4% from $13.3B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Nisa Investment Advisors deployed $862M of net new capital in Q1 2022, opening 306 new positions and adding to 502 existing holdings. Its largest new stake was Apple: 4,589,939 shares worth $801M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Microsoft, an estimated $69.6M trimmed.

  • Nisa Investment Advisors's largest Q1 2022 buy was Apple: 4,589,939 shares worth $801M.
  • Nisa Investment Advisors added most to iShares Core S&P 500 ETF in Q1 2022, an estimated $40.7M increase.
  • Nisa Investment Advisors's biggest Q1 2022 reduction was Microsoft, cutting an estimated $69.6M.
  • Nisa Investment Advisors fully exited NetEase in Q1 2022, selling an estimated $51.7M.
  • Nisa Investment Advisors's ten largest holdings make up 25% of its $14.2B portfolio in Q1 2022.
  • Nisa Investment Advisors opened 306 new positions and closed 89 in Q1 2022.
  • Nisa Investment Advisors's portfolio value rose 6.4% quarter-over-quarter to $14.2B.

Based on Nisa Investment Advisors's 13F filing for Q1 2022, filed 29 Apr 2022.